Literature DB >> 8449186

Clinically nonfunctioning pituitary adenomas.

P J Snyder1.   

Abstract

Clinically nonfunctioning pituitary adenomas do not produce a readily recognizable clinical syndrome attributable to hormonal secretion. Any kind of pituitary adenoma may be clinically nonfunctioning, but gonadotroph and thyrotroph adenomas are more likely to be nonfunctioning, lactotroph adenomas less likely, and somatotroph and corticotroph adenomas least likely. Clinically nonfunctioning adenomas usually come to medical attention when they become so large that they cause neurologic symptoms, especially visual impairment. Although they are difficult to recognize clinically, they can be identified in vivo by measurement of basal and TRH-stimulated concentrations of follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, and their subunits. They can also be recognized in vitro by secretion in culture, immunospecific staining, and probing for mRNAs. Primary treatment is usually transsphenoidal surgery, and adjunctive treatment may include supervoltage radiation, and occasionally, pharmacologic agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449186

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  8 in total

Review 1.  Radiotherapy for non-functioning pituitary tumors--when and under what circumstances?

Authors:  Neil J L Gittoes
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

Review 2.  Diagnosis and management of pituitary tumours.

Authors:  A Levy; S L Lightman
Journal:  BMJ       Date:  1994-04-23

3.  GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.

Authors:  A Münscher; M Schmid; W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 4.  Treatment of pituitary tumors: somatostatin.

Authors:  Maria A Tichomirowa; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

5.  Computer-Assisted Microscope Analysis of Feulgen-Stained Nuclei in Gonadotroph Adenomas and Null-Cell Adenomas of the Pituitary Gland.

Authors:  M. Beatriz S. Lopes; Isabelle Salmon; Nathalie Nagy; Christine Decaestecker; Jean-Lambert Pasteels; Edward R. Laws; Robert Kiss
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

6.  Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up.

Authors:  Luigi Ferrante; Giuseppe Trillò; Epimenio Ramundo; Paolo Celli; Marie-Lise Jaffrain-Rea; Maurizio Salvati; Vincenzo Esposito; Raffaele Roperto; Mattia Falchetto Osti; Giuseppe Minniti
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

7.  Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.

Authors:  Amelia Caretto; Roberto Lanzi; Cecilia Piani; Michela Molgora; Pietro Mortini; Marco Losa
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

Review 8.  Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques.

Authors:  Giuseppe Minniti; Marie-Lise Jaffrain-Rea; Mattia Osti; Giampaolo Cantore; Riccardo Maurizi Enrici
Journal:  Neurosurg Rev       Date:  2007-05-05       Impact factor: 2.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.